Konstantin Ertner

Dupilumab Treatment of Atopic Dermatitis in Routine Clinical Care: Baseline Characteristics of Patients in the PROLEAD Prospective, Observational Study

M. Augustin, D. Thaçi, R. von Kiedrowski, 2022, Dermatology and Therapy.

Long-Term Treatment with Dimethyl Fumarate for Plaque Psoriasis in Routine Practice: Good Overall Effectiveness and Positive Effect on Impactful Areas

K. Asadullah, M. Augustin, L. Landeck, 2022, Dermatology and Therapy.

Dupilumab Demonstrates Rapid Onset of Action in Improving Signs, Symptoms and Quality of Life in Adults with Atopic Dermatitis

M. Augustin, D. Thaçi, R. von Kiedrowski, 2023, Dermatology and Therapy.

Dupilumab but not cyclosporine treatment shifts the microbiome toward a healthy skin flora in patients with moderate‐to‐severe atopic dermatitis

K. Schäkel, W. Lieb, E. Haufe, 2023, Allergy.

Real‐world data on the effectiveness, safety and drug survival of dupilumab: an analysis from the TREATgermany registry

K. Schäkel, E. Haufe, A. Heratizadeh, 2022, The British journal of dermatology.

Itch, sleep loss, depressive symptoms, fatigue, and productivity loss in patients with moderate‐to‐severe atopic dermatitis: Analyses of TREATgermany registry data

K. Schäkel, E. Haufe, A. Heratizadeh, 2023, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

Itching and treatments in atopic dermatitis (AD): results from the German AD registry TREATgermany.

K. Schäkel, E. Haufe, J. Schmitt, 2022, The British journal of dermatology.